MARATTO

article · Benha Journal of Applied Sciences

Evaluation of Oncoplastic Techniques for Conservative Breast Surgery

Abstract

Background: Conservative breast surgery is crucial for breast cancer. Technique choice, like MRM and Reduction Mammoplasty, impacts cosmetic outcomes and patient quality of life. This aimed to compare outcomes of MRM and Reduction Mammoplasty respect to cosmetic results, postoperative complications, and overall patient satisfaction in breast cancer not responding to neoadjuvant chemotherapy. Methods: This comparative prospective wconducted on 30 breast cancer who met inclusion criteria. Fifteen were assigned to each group, one undergoing MRM axillary clearance and other undergoing Reduction Mammoplasty axillary clearance. All provided written informed consent and were thoroughly counseled regarding procedures and potential outcomes. Results: Reduction Mammoplasty wassociated a significantly longer mean operative time (2.7 ± 0.465 hours) compared to MRM (1.9 ± 0.425 hours). However, there wno statistically significant difference in intraoperative blood loss between two groups. Postoperative hospital stays were comparable, Group (1) (MRM) staying 1 to 3 days and Group (2) (Reduction Mammoplasty) staying 1 to 2.5 days. found similar rates of postoperative surgical complications, including wound infection, hematoma, and wound dehiscence, between two groups. : Both techniques, MRM and Reduction Mammoplasty, are viable for breast cancer not responding to neoadjuvant chemotherapy, comparable outcomes and complications.

Research topics

  • Breast Cancer Treatment Studies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/bjas.2024.263086.1309

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.